Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Universidad Complutense de Madrid
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are effective for weight loss but cause gastrointestinal side effects, affecting adherence
FOR POTENTIAL BENEFITS OF MEDICAL WEIGHT-LOSS PROGRAMS SOURCE: National Institute of Diabetes and Digestive and Kidney Diseases
Tirzepatide is a dual GIP/GLP-1 agonist that targets two incretin receptors simultaneously, producing more pronounced metabolic effects
By reducing appetite, stabilizing blood sugar, and supporting healthy eating habits, it helps patients achieve meaningful, long-term results
US$ 21.78
US$ 29.71
US$ 21.63
US$ 19.98
US$ 29.24
US$ 20.60
US$ 28.83
US$ 27.78
